SMMT Summit Therapeutics Inc.
Healthcare$16.49+0.00%OpenMarket Cap: $12.79B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$19.00
Target (Median)
$18.00
Target Range
$16.00 - $23.00
Upside from current price: 15.2%
Rating Distribution
1 Strong Buy11 Buy5 Hold0 Sell2 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-05-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-01 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-04-08 | Stifel | maintain | Buy | Buy |
| 2026-03-16 | Jefferies | downgrade | Hold | Buy |
| 2026-02-24 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-30 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-12-17 | Barclays | upgrade | Equal Weight | Underweight |
| 2025-10-22 | Guggenheim | maintain | Buy | Buy |
| 2025-10-21 | Barclays | maintain | Underweight | Underweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.14 | $77.4M | 8 |
| Sun Dec 31 | $-0.53 | $705.3M | 7 |
| Mon Dec 31 | $0.23 | $1.86B | 2 |
| Tue Dec 31 | $1.49 | $3.64B | 5 |